Processing your payment...
Please do not close your browser.

Lymphedema Diagnostics Market Growth, Trends And Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players - GE Healthcare, Siemens Healthineers

03 Jun, 2022 | 110 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

The global Lymphedema Diagnostics Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 7.9% during the review period (2022 to 2027)



Lymphedema Diagnostics Market Overview



Lymphedema is mostly a chronic illness that is usually characterized by swelling in any area of the body's tissues, most notably the arms and legs. It arises as a result of lymphatic system injury. It can also rise following breast cancer treatment. Given the history of a surgical operation or another condition that contains lymph node injury, the diagnosis of lymphedema is frequently obvious. Though lymphedema is incurable, treatment is offered for reducing the swelling. The common mode of treatment employed contain complex decongestive therapy. This therapy contains remedial exercises, skincare, manual lymphatic drainage, and multilayer lymphedema bandaging. The key cause of lymphedema is considered to be genetic mutations in genes involved in the development of the lymphatic system. Secondary causes of the disease include cancer surgery, radiation therapy, infection, and inflammatory conditions, among others. Lymphedema increases the risk of infections and other complications, as lymphocytes are not able to reach parts of the body where the swelling occurs. The growing incidence of chronic diseases such as cancer and lymphedema coupled with the increasing focus of quality of healthcare are the significant factors responsible for driving the progress of the lymphedema diagnostics market in the above-mentioned forecast period. Also, the rising investment and innovation of newer diagnostics modalities and the rising growth of the emerging countries such as China, India, Brazil, South Korea and Russia also heighten the overall growth of the market.



Industry News



GE Healthcare and Optellum Join Forces to Advance Lung Cancer Diagnosis with Artificial Intelligence



26 November 2021 - GE Healthcare and Optellum today announced that they have signed a letter of intent to collaborate to advance precision diagnosis and treatment of lung cancer. GE Healthcare is a global leader in medical imaging solutions. Optellum is the leader in AI decision support for the early diagnosis and optimal treatment of lung cancer.



What are the major Applications, Types and Regions for  Lymphedema Diagnostics Market?



By Type, it is segmented into




  • Lymphoscintigraphy

  • Magnetic Resonance Imaging

  • Ultrasound Imaging

  • Computed Tomography

  • X-Ray Lymphography

  • Bioimpedance Analysis

  • Near-Infrared Fluorescence Imaging

  • Others



By Applications it is segmented into




  • Cancer

  • Inflammatory Diseases

  • Cardiovascular Disease

  • Others



Lymphedema Diagnostics Market Regional Analysis



North America dominates the market due to the easy accessibility of the healthcare system. Asia-Pacific is expected to show a rapid and lucrative growth rate in the forecast period owing to the untapped growth opportunities in the region especially in, Japan, China, and India. The rising occurrence of chronic diseases and rising awareness about the early benefits.



North America






    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East & Africa

    • Latin America





The Lymphedema Diagnostics Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Lymphedema Diagnostics Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.



What is our Lymphedema Diagnostics Market Report Scope?























































Report Attributes



Report Details



Forecast Period 2022 to 2027 CAGR



CAGR of 7.9% during the review period (2022 to 2027).



By Type




  • Lymphoscintigraphy

  • Magnetic Resonance Imaging

  • Ultrasound Imaging

  • Computed Tomography

  • X-Ray Lymphography

  • Bioimpedance Analysis

  • Near-Infrared Fluorescence Imaging

  • Others



By Application




  • Cancer

  • Inflammatory Diseases

  • Cardiovascular Disease

  • Others



By Companies



GE Healthcare, Siemens Healthineers (A Subsidiary of Siemens Group), Philips, Canon, Inc., Shimadzu Corporation, Stryker Corporation, Fluoptics, United Imaging Healthcare Co., Ltd., Hitachi, Ltd., Esaote SPA, Neusoft Corporation, Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.), Mitaka Usa, Inc., Curadel, LLC



Regions Covered




  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World



Countries Covered




  • US

  • Canada

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Latin America



Base Year



2022



Historical Year



2017 to 2021



Forecast Year



2022 to 2027



Number of Pages



110



Customization Available



Yes, the report can be customized as per your needs




 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



Key Takeaways from this   Lymphedema Diagnostics Report




  • Evaluate  Lymphedema Diagnostics market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.

  • Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.

  • Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.

  • Analyze the sales and distribution channels across geographies to enhance top-line revenues.

  • Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.

  • Get a quick outlook on the   Lymphedema Diagnostics market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.

  • Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.



FAQ -



What is the study period of this market?



The Lymphedema Diagnostics Market is studied from 2017 - 2027.



 What is the growth rate of Lymphedema Diagnostics Market?



The Lymphedema Diagnostics Market is growing at a CAGR of 7.9% over the next 5 years.



What regions does this Lymphedema Diagnostics Market report covers?



North America (the United States, Canada, and Mexico)



Europe (Germany, France, UK, Russia, and Italy)



Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)



South America (Brazil, Argentina, Colombia, etc.)



The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)



All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.


  1. INTRODUCTION

    1. MARKET DEFINATION

    2. MARKET DYNAMICS

    3. MARKET SEGMENTATION

    4. REPORT TIMLINES

    5. KEY STAKEHOLDERS



  2. RESEARCH METHODOLOGY

    1. DATA MINING

      1. SECONDARY RESEARCH

      2. PRIMARY RESEARCH

      3. SUBJECT MATTER EXPERT ADVICE



    2. QUALITY CHECK

    3. FINAL REVIEW

      1. DATA TRIANGULATION

      2. BOTTOM-UP APPROACH

      3. TOP-DOWN APPROACH

      4. RESEARCH FLOW





  3. EXECUTIVE SUMMARY

    1. INTRODUCTION

    2. GLOBAL  LYMPHEDEMA DIAGNOSTICS MARKET BY TYPES

    3. GLOBAL  LYMPHEDEMA DIAGNOSTICS MARKET BY APPLICATIONS



  4. MARKET DYNAMICS

    1. DRIVERS

      1. INCREASING DEMAND FOR  LYMPHEDEMA DIAGNOSTICS



    2. RESTRAINTS

      1. STRINGENT ENVIRONMENTAL REGUALTIONS

      2. HIGH COST ON MATERIALS



    3. OPPORTUNITIES

      1.  LYMPHEDEMA DIAGNOSTICS GROWTH

      2. APPLICATION OF  LYMPHEDEMA DIAGNOSTICS



    4. IMPACT OF COVID 19



  5. GLOBAL  LYMPHEDEMA DIAGNOSTICS MARKET, BY TYPES

    1. Introduction

    2. Lymphoscintigraphy

    3. Magnetic Resonance Imaging

    4. Ultrasound Imaging

    5. Computed Tomography

    6. X-Ray Lymphography

    7. Bioimpedance Analysis

    8. Near-Infrared Fluorescence Imaging

    9. Other            



  6. GLOBAL  LYMPHEDEMA DIAGNOSTICS MARKET, BY APPLICATION

    1. Introduction

    2. Cancer

    3. Inflammatory Diseases

    4. Cardiovascular Disease

    5. Others   



  7. GLOBAL  LYMPHEDEMA DIAGNOSTICS MARKET, BY REGION

    1. NORTH AMERICA

      1. US

      2. CANADA

      3. MEXICO



    2. EUROPE

      1. GERMANY

      2. FRANCE

      3. UK

      4. ITALY

      5. RUSSIA

      6. REST OF EUROPE



    3. APAC

      1. CHINA

      2. SOUTH KOREA

      3. JAPAN

      4. INDIA

      5. AUSTRALIA

      6. ASEAN

      7. REST OF APAC



    4. MIDDLE EAST & AFRICA

      1. SAUDI ARABIA

      2. UAE

      3. SOUTH AFRICA

      4. TURKEY

      5. REST OF MEA



    5. SOUTH AMERICA

      1. BRAZIL

      2. REST OF MEA

      3. ARGENTINA

      4. REST OF SOUTH AMERICA





  8. COMPETITIVE LANDSCAPE

    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,

    2. AND AGREEMENTS

      1. KEY DEVELOPMENT



    3. MARKET SHARE (%) **/RANKING ANALYSIS

    4. STRATEGIES ADOPTED BY LEADING PLAYERS



  9. COMPANY PROFILES

    1. BUSINESS OVERVIEW

    2. COMPANY SNAPSHOT

    3. PRODUCT BENCHMARKING

    4. STRATEGIC INITIATIVES

      1. GE Healthcare,

      2. Siemens Healthineers (A Subsidiary of Siemens Group),

      3. Philips,

      4. Canon, Inc.,

      5. Shimadzu Corporation,

      6. Stryker Corporation,

      7. Fluoptics,

      8. United Imaging Healthcare Co., Ltd.,

      9. Hitachi, Ltd.,

      10. Esaote SPA,

      11. Neusoft Corporation,

      12. Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.),

      13. Mitaka Usa, Inc.,

      14. Curadel, LLC





SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Merck
  • IBM
  • Dow
  • Henkel
  • AirBus
  • Cummins
  • Intel
  • Sony
  • 9
  • 3M